The Adoption and Use of Artificial Intelligence and Machine Learning in Clinical Development
- 29 May 2025
- journal article
- research article
- Published by Springer Nature in Therapeutic Innovation & Regulatory Science
- p. 1-13
Abstract
Background The use of artificial intelligence (AI) and machine learning (ML) in drug discovery has been well documented, but measures of levels of adoption, investments, and efficiencies gained from its use in clinical development have not yet been developed, captured or published. AI/ML use in clinical development is expected to increase, but its impact has not yet been systematically measured until now. Methods The Tufts Center for the Study of Drug Development conducted a global online survey among pharmaceutical and biotechnology companies, contract research organizations (CROs), and data and technology vendors servicing drug developers. The survey gathered 302 responses assessing levels of AI/ML implementation across 36 distinct clinical trial planning and design, trial execution, and regulatory submission activities. The survey collected data on US dollar investment, time savings, and challenges and opportunities of AI/ML use in clinical development. Results Approximately one-third of the sample (36.9%) was not yet using or implementing AI/ML across 36 design and planning, execution, and regulatory submission activities; another 30.3% was beginning their AI/ML implementation (or piloting), 22.1% was partially implementing (or moving beyond pilots), and on average only 10.7% had fully implemented AI/ML (i.e., uses AI in most trials employing a repeatable process).Keywords
This publication has 26 references indexed in Scilit:
- General Data Protection Regulation: Current Challenges and Future Directions2024
- An Open-Source R Package for Detection of Adverse Events Under-Reporting in Clinical Trials: Implementation and Validation by the IMPALA (Inter coMPany quALity Analytics) ConsortiumTherapeutic Innovation & Regulatory Science, 2024
- Ética e inteligencia artificialRevista Clínica Española, 2024
- Artificial Intelligence Applied to clinical trials: opportunities and challengesHealth and Technology, 2023
- Predicting amyloid risk by machine learning algorithms based on the A4 screen data: Application to the Japanese Trial‐Ready Cohort studyAlzheimer's & Dementia: Translational Research & Clinical Interventions, 2021
- Assessing the Scope and Predictors of Intentional Dose Non-adherence in Clinical TrialsTherapeutic Innovation & Regulatory Science, 2020
- Matching patients to clinical trials using semantically enriched document representationJournal of Biomedical Informatics, 2020
- Improving Clinical Trial Participant Prescreening With Artificial Intelligence (AI): A Comparison of the Results of AI-Assisted vs Standard Methods in 3 Oncology TrialsTherapeutic Innovation & Regulatory Science, 2020
- Enabling Data-Driven Clinical Quality Assurance: Predicting Adverse Event Reporting in Clinical Trials Using Machine LearningDrug Safety, 2019
- Innovation in Pharmacovigilance: Use of Artificial Intelligence in Adverse Event Case ProcessingClinical Pharmacology & Therapeutics, 2018